Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine.
Authors:
- J R AtackJAJ R Atack
- I LitvanILI Litvan
- L J ThalLTL J Thal
- C MayCMC May
- S I RapoportSRS I Rapoport
- T N ChaseTCT N Chase
Open Access
- 1 September 1991
- journal article
- clinical trial
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 54 (9) , 832-835
Abstract
Acetylcholinesterase (AChE) activity was measured in lumbar cerebrospinal fluid (CSF) of 11 patients with progressive supranuclear palsy (PSP) and 18 age-matched healthy control subjects. Mean CSF AChE activity in PSP subjects was significantly reduced by 31% relative to control subjects (p less than 0.002). In the light of evidence of a central cholinergic deficit, physostigmine was administered orally (0.5-2.0 mg every two hours, six times a day for 10 days) to eight of the 11 PSP patients. CSF was sampled when the patients were on placebo and when receiving physostigmine and CSF AChE and butyrylcholinesterase (BChE) activities were measured. There was no significant change in either CSF AChE or BChE activities following physostigmine treatment. These data suggest that the doses of physostigmine used were insufficient to produce marked inhibition of AChE within the central nervous system.Keywords
This publication has 22 references indexed in Scilit:
- Physostigmine treatment of progressive supranuclear palsyAnnals of Neurology, 1989
- Cerebrospinal fluid cholinesterases in aging and in dementia of the alzheimer typeAnnals of Neurology, 1988
- Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous SystemJournal of Neurochemistry, 1986
- Bioavailability of Oral PhysostigmineNew England Journal of Medicine, 1985
- Dopaminergic and cholinergic lesions in progressive supranuclear palsyAnnals of Neurology, 1985
- Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markersAnnals of Neurology, 1985
- Progressive supranuclear palsy: Postmortem chemical analysisAnnals of Neurology, 1985
- PLASMA PHYSOSTIGMINE CONCENTRATIONS AFTER ORAL ADMINISTRATIONThe Lancet, 1985
- The occurrence of large acetylcholinesterase-containing neurons in human neostriatum as disclosed in normal and Alzheimer-diseased brainsBrain Research, 1984
- Projections of the pedunculopontine tegmental nucleus in the rat: evidence for additional extrapyramidal circuitryBrain Research, 1982